glp-1 vs gip-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

Medicina (Kaunas) 49(7):301309 Kobayashi A, Ohta T, Yamamoto M (2004) Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes

GLP-1 medications carry black box warnings and potential side effects - commonly including nausea, vomiting, diarrhea, constipation, and abdominal pain - and require ongoing medical supervision

The FDA has deep concerns about its safety and efficacy

Heres How Hormones May Interact With GLP-1s in Women GLP-1s may help with PMOS (polyendocrine metabolic ovarian syndrome)

Yes, oral semaglutide is an exceptionally strong candidate for patients with prediabetes or metabolic syndrome